Interestingly, PRODH was also shown as capable of promoting tumor progression in non-small cell lung cancer (NSCLC) as part of a network involving a chromatin remodeler, the lymphoid-specific helicase (LSH) (Liu et al. 2020b). The gene discussed is HELLS; the disease is neoplasm.